Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association
about
Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell linesThe viral etiology of AIDS-associated malignanciesA lymphomagenic role for HIV beyond immune suppression?Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developmentsHow I treat HIV-associated lymphomaTargeting of prosurvival pathways as therapeutic approaches against primary effusion lymphomas: past, present, and FutureMutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphomaPrimary effusion lymphoma associated with Human Herpes Virus-8 and Epstein Barr virus in an HIV-infected woman from Kampala, Uganda: a case reportPre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.KS-Detect - Validation of Solar Thermal PCR for the Diagnosis of Kaposi's Sarcoma Using Pseudo-Biopsy SamplesThe latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma.Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomasKSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma.EBV and HIV-Related LymphomaTumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines.Chromatinization of the KSHV Genome During the KSHV Life Cycle.EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.Modern management of non-Hodgkin lymphoma in HIV-infected patients.Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome.Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature.Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesisKaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disordersUnderstanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcomaKaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and ApoptosisVirus-associated lymphomagenesis.Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?Primary effusion lymphoma in an elderly patient effectively treated by lenalidomide: case report and review of literature.Extrafollicular activities: perspectives on HIV infection, germinal center-independent maturation pathways, and KSHV-mediated lymphoproliferation.Major Histocompatibility Complex Class II HLA-DRα Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8.Murine gammaherpesvirus 68 reactivation from B cells requires IRF4 but not XBP-1.KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation.Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma.X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma.Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma.Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.Nuclear factor kappa B pathway associated biomarkers in AIDS defining malignancies.
P2860
Q16258509-BDC910A9-3607-4CDA-B966-799EE6E2ECD9Q4835216-26DCDC0C-1FE8-445D-9B9F-AB5D988A9DEEQ54795185-DE191266-F156-480D-B7B7-FAD322F4AB72Q54795187-D149043E-DF3F-4D66-8599-73EB1BB19A0BQ54795189-7F8494F1-DB22-4778-B1B5-8F9EF316B7E2Q54795195-ECFD8DCB-1EDC-4A71-B016-D663BAE89FEEQ54795334-4F2B330D-6D1A-4017-9A6F-43252AEA6AF5Q54795609-41B87D8C-0EDC-4386-8B6A-9149EA4FE3E5Q54795721-7E61ADF7-5DDD-479E-8CEB-1D9BE1223C9CQ54897179-F70AAFAD-B370-4667-A54B-019D5567D86DQ54899065-98E259BF-994A-4AB2-A999-76EA2E5F370DQ54946907-DBF6ADA4-C240-43EE-8878-3464BF6FB006Q54954884-BFE5D3B7-3E9B-402D-87BE-C4BC243FE05B
P1343
Q24594085-3B3244E5-AD84-4A1C-9ECF-B0BEF15AEE78Q24685892-9ADE035D-12F3-4D38-A3AE-064630BC327BQ26771672-67936F6C-6AE9-43FD-BAA6-5FDAAA5C5B9BQ26775442-6330259C-AA30-4BCE-B2F8-78375972C68EQ26821860-6817D8A2-0AA6-4466-B252-16B85F04BF5DQ28081199-B9D35A25-F0CE-4A44-BB5A-C9C2C54505C9Q28472086-D3026142-E687-4CAB-A625-AAD4BB4C9CBFQ30399671-6C7764DF-750C-4D6C-BAAA-16B8899FC21BQ33432690-7EDC8A2E-B724-49A5-B87F-61F42092B718Q33446895-9F3FED4D-5900-40CE-B914-333101A16E01Q34391203-7EDE7DAD-1195-4F46-9DED-2F13B574C655Q34395302-06FD7859-3343-4DD2-A6E6-31C71DA14D1FQ34417383-576216B3-F974-4442-AC67-016BF0165447Q34480968-17086AA6-F9EC-4F28-9976-B22594689749Q34549450-22D4C667-DAB2-4B45-BBDB-2C1123877825Q35172518-AC2322C7-7274-40A9-BD9C-92481251D3C0Q35237492-3C49A673-9227-40B0-AF4E-4DE3A3FB589DQ36508964-E3734D34-061C-417A-9C7B-659F797AA195Q36710347-F12A7334-B37D-4EDB-8832-A65DD0D62BDFQ36734697-A7E19A31-8D90-4638-AA86-2350A17D09E9Q36846805-BCE05CFD-D389-44B4-925F-60E19DFAD174Q36882284-95453423-FECD-4197-A903-31CE1672905FQ37016504-A644A1D9-6EF2-4F45-B97B-F41C6885313AQ37088015-F1F88E68-3CF6-40D4-9900-07722A385F88Q37146126-EF7910A5-69F6-4913-8DF3-3F8EB5357AB2Q37237479-42FAD6F6-8822-4A55-A5CE-98BB1D90AD29Q37593234-9AE53474-3C02-40C8-9C85-4E37FBA0A5CAQ38106958-544C5B3B-92D4-4ABE-BD51-ABB30C0DAD43Q38186778-A6293355-6A56-4623-A755-6874CE0800FFQ38194434-AA69529A-A459-46BB-8E2C-5BFD90E8DD94Q38646535-7E1F1FC9-A9AA-4A97-A536-4DCBC36F6B8FQ38760916-008B58F7-FC16-42CA-BB8F-C7FC58419F46Q38970026-C2D13546-EF9F-4F8B-B88F-C9902E23B74BQ39046910-AB9ED0CA-0203-43BE-ABB2-D8D984040648Q39162733-CDC0AF9F-FD8D-44E4-9B19-DB27762190FFQ39639121-851E0166-2A56-4BA6-9360-1B8BDFFD8DA9Q40155828-892B2934-A2EB-42D9-B9A8-1A0E29704D7BQ40210866-17A75734-588E-4A23-BFCF-69ACCC7C8A5FQ40287215-BCB84F7D-CDC7-4D60-B683-9A041E02ED85Q40641957-35887ACB-B923-4504-96F4-8EC850C15AE0
P2860
Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Distinct subsets of primary ef ...... profile and viral association
@ast
Distinct subsets of primary ef ...... profile and viral association
@en
Distinct subsets of primary ef ...... profile and viral association
@nl
type
label
Distinct subsets of primary ef ...... profile and viral association
@ast
Distinct subsets of primary ef ...... profile and viral association
@en
Distinct subsets of primary ef ...... profile and viral association
@nl
prefLabel
Distinct subsets of primary ef ...... profile and viral association
@ast
Distinct subsets of primary ef ...... profile and viral association
@en
Distinct subsets of primary ef ...... profile and viral association
@nl
P2093
P2860
P4510
P1433
P1476
Distinct subsets of primary ef ...... profile and viral association
@en
P2093
Amy Chadburn
Daniel M Knowles
Darya Bubman
Ethel Cesarman
William J Harrington
P2860
P304
P356
10.1128/JVI.79.2.1244-1251.2005
P407
P577
2005-01-01T00:00:00Z